In a recent study, it has been shown that TREM2 has emerged as a promising therapeutic target for AD treatment since TREM2 overexpression rescued cognitive impairments in mice models by inhibiting microglia‐mediated neuroinflammation (Deczkowska et al., 2018). The gene discussed is TREM2; the disease is Alzheimer disease.